Parkinson Disease Clinical Trial
Official title:
The Purpose of This Study is to Determine if the 9zest App for Parkinson's Disease (PD) is Feasible, Safe, and Efficacious When Used Independently by Individuals With Parkinson's Disease
The purpose of this study is to determine if the 9zest app for Parkinson's disease is feasible, safe, and efficacious when used independently by individuals with Parkinson's disease.
The investigators will evaluate the 9zest app using a non-randomized, single-group design
wherein participants who have downloaded the 9zest app will be informed via a message in the
app about the trial and invited to participate. If the participant answers yes to the
invitation the participant will be consented through a questionnaire in the app. In the
consent form for participation, prospective participants will learn the eligibility criteria.
If the participant completes the informed consent process, the participant will then be
required to answer specific inclusion and exclusion criteria questions to ensure
qualification for the study. A phone number that goes directly to a member of the research
team will be provided if the prospective participant has any questions during the informed
consent process.
Outcome measurements. After completing the consent process and prior to participation in the
12-week trial, participants will answer several questions about specific symptoms to complete
their registration and profile. The participant will then be asked to perform a couple of
pretest outcome measures via the app. Participants will also be tested at the 4 week, 8 week,
and 12 week marks.
Exercise intervention. The 12-week app guided exercise intervention is a personalized
exercise regimen. Participants will use the smartphone/tablet app for the study period of 12
weeks. While the app has been developed to deliver physical therapy in a variety of movement
disorders including multiple system atrophy, progressive supranuclear palsy, and dementia
with Lewy bodies, users will choose the PD track for the purposes of the study, which is the
population of interest. The participants will create a PD profile with a series of questions
to assess the current level of functioning. A proprietary algorithm (9zest Smart™) developed
by physical therapists and information technologists chooses the appropriate workout regimen
for the person's level of function. The customized regimen is intended to be safe and
effective for the participant. The 9zest App Family has over 1,000 original therapy videos in
its library, which encompasses Physical Therapy, Fitness, Yoga, Meditation, and Speech
Therapy. 9zest Smart™, the app's intelligent engine determines the right set and levels of
exercises for a user based on the Smart Assessment responses. At preset intervals (generally
after 2 weeks), the app will again assess the user's functional capacity and needs. Again,
the 9zest Smart algorithm will adjust the type, duration, and intensity of the regimen to
maximize performance. All of the exercises and dosing features are consistent with
contemporary and evidence-based physical therapy practice. Additionally, the exercises have
all been deemed to be safe by physical therapists for each particular level of function. The
exercise program is imbedded in the app. A demonstration of the exercise is shown in
audiovisual format and then the participant follows along with the exercise in real time.
Participants in the trial will be asked to participate in the 12-week exercise program with
the goal of participating 3 times per week with each session lasting 60 minutes. After the
trail is over, the investigators will sort and analyze the data based on compliance (eg, high
engagers, moderate engagers, low engagers).
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT05415774 -
Combined Deep Brain Stimulation in Parkinson's Disease
|
N/A | |
| Recruiting |
NCT04691661 -
Safety, Tolerability, Pharmacokinetics and Efficacy Study of Radotinib in Parkinson's Disease
|
Phase 2 | |
| Active, not recruiting |
NCT05754086 -
A Multidimensional Study on Articulation Deficits in Parkinsons Disease
|
||
| Completed |
NCT04045925 -
Feasibility Study of the Taïso Practice in Parkinson's Disease
|
N/A | |
| Recruiting |
NCT04194762 -
PARK-FIT. Treadmill vs Cycling in Parkinson´s Disease. Definition of the Most Effective Model in Gait Reeducation
|
N/A | |
| Completed |
NCT02705755 -
TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
|
Phase 2 | |
| Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
| Recruiting |
NCT05830253 -
Free-living Monitoring of Parkinson's Disease Using Smart Objects
|
||
| Recruiting |
NCT03272230 -
Assessment of Apathy in a Real-life Situation, With a Video and Sensors-based System
|
N/A | |
| Recruiting |
NCT06139965 -
Validity and Reliability of the Turkish Version of the Comprehensive Coordination Scale in Parkinson's Patients
|
||
| Completed |
NCT04580849 -
Telerehabilitation Using a Dance Intervention in People With Parkinson's Disease
|
N/A | |
| Completed |
NCT03980418 -
Evaluation of a Semiconductor Camera for the DaTSCAN™ Exam
|
N/A | |
| Completed |
NCT04477161 -
Effect of Ketone Esters in Parkinson's Disease
|
N/A | |
| Completed |
NCT04942392 -
Digital Dance for People With Parkinson's Disease During the COVID-19 Pandemic
|
N/A | |
| Terminated |
NCT03446833 -
LFP Beta aDBS Feasibility Study
|
N/A | |
| Completed |
NCT03497884 -
Individualized Precise Localization of rTMS on Primary Motor Area
|
N/A | |
| Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
| Recruiting |
NCT04997642 -
Parkinson's Disease and Movement Disorders Clinical Database
|
||
| Completed |
NCT04117737 -
A Pilot Study of Virtual Reality and Antigravity Treadmill for Gait Improvement in Parkinson
|
N/A | |
| Recruiting |
NCT03618901 -
Rock Steady Boxing vs. Sensory Attention Focused Exercise
|
N/A |